A ustarPharma is a pharmaceutical company specializing in drug delivery technologies with a team of highly experienced professionals. Our management team members have over twenty-five years of experience on average in the pharmaceutical industry.

AustarPharma is a pharmaceutical company specializing in drug delivery technologies with a team of highly experienced professionals. Our management team members have over twenty-five years of experience on average in the pharmaceutical industry. Our core competence is water-insoluble drug delivery and controlled-release drug delivery.

2024年2月6日 · 近日，同属玻思韬体系的AustarPharma（下简称“奥思达”）研发的治疗痛风口溶膜 (项目代号: AP011) 新药的IND申请获得美国食品药品监督管理局(FDA) 批准，可正式开展临床试验。

Drug Development Technology & Services. A ustarPharma has an experienced R&D team with deep scientific expertise and practical know-how in multiple drug delivery technology platforms. We have a wide range of pharmaceutical processing technology and capability to meet various development and manufacturing needs, whether it is a new chemical entity or a …

了解Austarpharma, Inc. (Austarpharma, Inc.)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验，疾病领域:免疫系统疾病，技术平台:小分子化药，药物:MH080，Firzacorvir。

AustarPharma, LLC is an emerging and innovative pharmaceutical company with focus on the drug delivery and generic drug products.

近日，同属玻思韬体系的AustarPharma（下简称“奥思达”）研发的治疗痛风口溶膜 (项目代号: AP011) 新药的IND申请获得美国食品药品监督管理局(FDA) 批准，可正式开展临床试验。

香港奥星集团致力于以领先科技服务生命科学，在生命科学工艺技术、应用、行业监管规则和实践方面拥有全面的知识和经验，帮助客户解决质量、合规和卓越运营方面的问题，致力于提供设备-工程-服务-耗材的交钥匙解决方案，推动行业进步，持续创造价值。

AustarPharma公司是一家美国医药公司，位于美国新泽西州。 新泽西州是美国药物研发的前沿，享有独特的地域优势，那里聚集了70%以上的国际知名医药公司的总部和研发中心。

Austarpharma is a pharmaceutical company. It offers alendronate sodium tablets, methocarbamol tablets USP, and other products. The company provides water-insoluble drug delivery technologies, controlled-release platform technologies, …